Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Management and efficacy of intensified insulin therapy — Starting in outpatients

  • 17 Accesses

  • 3 Citations

Summary

Diabetic patients under multiple injection insulin therapy (i.e., intensified insulin therapy, IIT) usually start this treatment during hospitalization. We report here on the logistics, efficacy, and safety of IIT, started in outpatients. Over 8 months, 52 type I and type II diabetics were followed up whose insulin regimens consecutively had been changed from conventional therapy to IIT. Two different IIT strategies were compared: free mixtures of regular and intermediate (12 hrs)-acting insulin versus the basal and prandial insulin treatment with preprandial injections of regular insulin, and ultralente (24 hrs-acting) or intermediate insulin for the basal demand. After 8 months HbA1 levels had decreased from 10.6%±2.4% to 8.0%±1.3% (means±SD). There was no difference between the two regimens with respect to metabolic control; but type II patients maintained the lowered HbA1 levels better than type I patients. Only two patients were hospitalized during the follow-up time because of severe hypoglycemia. An increase of body weight due to the diet liberalization during IIT became a problem in one-third of the patients. Our results suggest that outpatient initiation of IIT is safe and efficacious with respect to near-normoglycemic control. Weight control may become a problem in IIT patients.

This is a preview of subscription content, log in to check access.

Abbreviations

BPIT:

basal and prandial insulin therapy

FMIT:

free mixture insulin therapy

IIT:

intensified insulin therapy

References

  1. 1.

    Berger M, Cüppers HJ, Hegner H, Jörgens V, Berchtold P (1982) Absorption kinetics and biological effects of subcutaneously injected insulin preparations. Diabetes Care 5:77–91

  2. 2.

    Berger AS, Saurbrey N, Kühl C, Villumsen J (1985) Clinical experience with a new device that will simplify insulin injections. Diabetes Care 8:73–76

  3. 3.

    Capper FA, Headen SW, Bergenstal RM (1985) Dietary practices of persons with diabetes during insulin pump therapy. J Am Diet Assoc 85:445–449

  4. 4.

    Chantelau EA, Frenzen A, Gösseringer G, Hansen I, Berger M (1987) Intensive insulin therapy justifies simplification of the diabetes diet: a prospective study in insulin-dependent diabetic patients. Am J Clin Nutr 45:958–996

  5. 5.

    Hanssen KF, Dahl-Joergensen K, Lauritzen T, Feldt-Rasmussen B, Brinchmann-Hansen O, Deckert T (1986) Diabetic control and microvascular complications: the near-normoglycaemic experience. Diabetologia 29:677–684

  6. 6.

    Heinze P, Stahl A, Glasmacher A, Ahlert U (1988) Intensiviertes Insulintherapieregime: Tags multiple Injektionen eines kurzwirkenden Insulins, nachts Verzögerungsinsulin als “Bedside-Dosis”. Akt Endokr Stoffw 9:112

  7. 7.

    Holman RR, Turner RC (1985) A practical guide to basal and prandial insulin therapy. Diabet Med 2:45–53

  8. 8.

    Jörgens V, Berger M, Hornke L (1982) Die Bedeutung der Patientenschulung in der Behandlung des Diabetes mellitus. Deutsch Ärzteblatt 79:47–50

  9. 9.

    Krönke HJ, Sieber J, Reuber E, Lütke-Twenhöven A, Rathmann W, Bertrams J (1987) Langzeitergebnisse bei 45 Diabetikern mit dem Basis-Bolus-Insulin-Regime. Akt Endokr Stoffw 8:206

  10. 10.

    Marble A (1985) Insulin in the treatment of diabetes. In: Marble A, Krall CP, Bradley RF, Christlieb AR, Soeldner JS (eds) Joslin's Diabetes mellitus, 12th edn. Lea and Febinger, Philadelphia, pp 380–405

  11. 11.

    Rizza RA, Gerich JE, Haymond MW, et al. (1980) Control of blood sugar in insulin-dependent diabetes: comparison of an artificial endocrine pancreas, continuous subcutaneous insulin infusion, and intensified conventional insulin therapy. N Engl J Med 303:1313–1318

  12. 12.

    Rosak C, Böhm BO, Althoff PH, Schöffling K (1986) The basis-bolus-concept in insulin-therapy: renaissance of an old therapeutical regime. Med Klinik 81:341–345

  13. 13.

    Roth E, Ollenschläger G, Hackl JM (1985) Grundlagen und Technik der Infusionstherapie und klinischen Ernährung. In: Reissigl H (Hrsg) Handbuch der Infusionstherapie und klinischen Ernährung, Band II. Karger, Basel München, S 38

  14. 14.

    Sachs L (1984) Angewandte Statistik, 6th edn. Springer, Berlin Heidelberg New York

  15. 15.

    Schiffrin A (1982) Treatment of insulin-dependent diabetes with multiple subcutaneous insulin injections. In: Raskin R (ed) Symposium on diabetes mellitus. Med Clin North Am 66:1251–1267

  16. 16.

    Spuck W, Schweinebraten A, Thun C, Gerdes H (1987) Intensified insulin therapy: single dose substitution of non-meal-related (basal) insulin by long acting human zinc insulin. Med Klinik 82:51–55

  17. 17.

    The DCCT Research Group (1987) Diabetes control and complications trial (DCCT): results of a feasibility study. Diabetes Care 10:1–19

  18. 18.

    Whitehouse FW, Whitehouse IJ, Cox MS, et al. (1983) Outpatient regulation of the insulin-requiring person with diabetes (an alternative to hospitalization). J Chron Dis 36:433–438

  19. 19.

    Wilson RM, Clarke P, Barkes H, Heller SR, Tattersall RB (1986) Starting insulin treatment as an outpatient. Report of 100 consecutive patients followed up for at least one year. JAMA 256:877–880

Download references

Author information

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Ollenschläger, G., Hummerich, W., Steffen, M. et al. Management and efficacy of intensified insulin therapy — Starting in outpatients. Klin Wochenschr 67, 60–65 (1989). https://doi.org/10.1007/BF01735653

Download citation

Key words

  • Intensified insulin therapy
  • Outpatient treatment
  • Diabetes mellitus